|Articles|May 6, 2003
Robotically implanted, bioengineered microfistula shows promise as innovation for glaucoma drainage surgery
Ft. Lauderdale-Robotic biological microfistula implantation appears to be a reliable and controllable way to produce a scleral channel between the anterior chamber and subconjunctival space based on animal trials.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocumetics reports first-in-human data investigational accommodating IOL in severe vision loss
2
Metformin use associated with reduced incidence of intermediate AMD
3
EnVision Summit 2026: Ultimate gathering place for ophthalmic education
4
Sandoz Canada launches aflibercept biosimilar, Enzeevum
5
























